Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Hillary Samples

Showing results (31-40 of 74) with videos related to

Pageof 8
Sort By:
The American Journal of Drug and Alcohol Abuse|November 24, 2025
Pharmacotherapy and overdose risk following new opioid use disorder diagnosis among Medicaid beneficiariesPeter Treitler, Hillary Samples, Richard Hermida, et al.
Drug and Alcohol Dependence|January 17, 2022
Opioid overdose survivors: Medications for opioid use disorder and risk of repeat overdose in Medicaid patientsStephen Crystal, Molly Nowels, Hillary Samples, et al.
Journal of the American Academy of Child and Adolescent Psychiatry|December 19, 2025
Nonfatal Drug Overdose in a National Sample of Adolescents by Intent and Substance, Medicaid 2016-2020Greta Bushnell, Mark Olfson, Diane P Calello, et al.
Journal of Substance Abuse Treatment|August 15, 2021
Medically treated opioid overdoses among New Jersey Medicaid beneficiaries: Rapid growth and complex comorbidity amid growing fentanyl penetrationStephen Crystal, Molly Nowels, Mark Olfson, et al.
American Journal of Preventive Medicine|June 1, 2026
Opioid use disorder, pharmacotherapy, and overdose among Medicare disability beneficiaries from 2008-2021Peter Treitler, Jennifer Miles, Elizabeth M Stone, et al.
American Journal of Preventive Medicine|August 14, 2025
Buprenorphine Dispensation After X-Waiver Elimination by Clinician SpecialtyElizabeth M Stone, Fangzhou Xie, Jennifer Miles, et al.
JAMA Network Open|June 1, 2022
Racial and Ethnic Disparities in Buprenorphine and Extended-Release Naltrexone Filled Prescriptions During the COVID-19 PandemicThuy Nguyen, Engy Ziedan, Kosali Simon, et al.
JAMA Network Open|February 18, 2026
Medicaid Expansion and Buprenorphine Dispensing in Early vs Recent Expansion StatesNicole Siegal, Sumedha Gupta, Jennifer Miles, et al.
Preventive Medicine|July 5, 2016
The emerging public discourse on state legalization of marijuana for recreational use in the US: Analysis of news media coverage, 2010-2014Emma E McGinty, Hillary Samples, Sachini N Bandara, et al.
The International Journal on Drug Policy|July 31, 2022
A modified Delphi process to identify experts' perceptions of the most beneficial and harmful laws to reduce opioid-related harmLeah K Hamilton, Katherine Wheeler-Martin, Corey S Davis, et al.
Pageof 8

Showing results (31-40 of 74) with videos related to

Sort By:
Pageof 8
The American Journal of Drug and Alcohol Abuse|November 24, 2025
Pharmacotherapy and overdose risk following new opioid use disorder diagnosis among Medicaid beneficiariesPeter Treitler, Hillary Samples, Richard Hermida, et al.
Drug and Alcohol Dependence|January 17, 2022
Opioid overdose survivors: Medications for opioid use disorder and risk of repeat overdose in Medicaid patientsStephen Crystal, Molly Nowels, Hillary Samples, et al.
Journal of the American Academy of Child and Adolescent Psychiatry|December 19, 2025
Nonfatal Drug Overdose in a National Sample of Adolescents by Intent and Substance, Medicaid 2016-2020Greta Bushnell, Mark Olfson, Diane P Calello, et al.
Journal of Substance Abuse Treatment|August 15, 2021
Medically treated opioid overdoses among New Jersey Medicaid beneficiaries: Rapid growth and complex comorbidity amid growing fentanyl penetrationStephen Crystal, Molly Nowels, Mark Olfson, et al.
American Journal of Preventive Medicine|June 1, 2026
Opioid use disorder, pharmacotherapy, and overdose among Medicare disability beneficiaries from 2008-2021Peter Treitler, Jennifer Miles, Elizabeth M Stone, et al.
American Journal of Preventive Medicine|August 14, 2025
Buprenorphine Dispensation After X-Waiver Elimination by Clinician SpecialtyElizabeth M Stone, Fangzhou Xie, Jennifer Miles, et al.
JAMA Network Open|June 1, 2022
Racial and Ethnic Disparities in Buprenorphine and Extended-Release Naltrexone Filled Prescriptions During the COVID-19 PandemicThuy Nguyen, Engy Ziedan, Kosali Simon, et al.
JAMA Network Open|February 18, 2026
Medicaid Expansion and Buprenorphine Dispensing in Early vs Recent Expansion StatesNicole Siegal, Sumedha Gupta, Jennifer Miles, et al.
Preventive Medicine|July 5, 2016
The emerging public discourse on state legalization of marijuana for recreational use in the US: Analysis of news media coverage, 2010-2014Emma E McGinty, Hillary Samples, Sachini N Bandara, et al.
The International Journal on Drug Policy|July 31, 2022
A modified Delphi process to identify experts' perceptions of the most beneficial and harmful laws to reduce opioid-related harmLeah K Hamilton, Katherine Wheeler-Martin, Corey S Davis, et al.
Pageof 8